Page 2901 - Cote clinical veterinary advisor dogs and cats 4th

1548 Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.

Nonsteroidal antiinflammatory drugs (NSAIDs) Nymphomania, 822 Olsalazine
(Continued) Nystagmus, 698–700. See also Vestibular disease administration and dosage of, 1498
for inflammatory bowel disease, 545
Nystatin, 1496
for hip luxation, 473
VetBooks.ir for hypertrophic osteodystrophy, 508 Nystex. See Nystatin Omega-3 fatty acids
for intervertebral disc disease, 556
allergy testing and, 92
O
for neck pain, 684
for atopic dermatitis, 93
for necrotizing fasciitis, 685
for dilated cardiomyopathy, 265
causes of, 1261
for orbital abscess, 717 Obesity, 700–701, 701.e1f–701.e2f for dermatomyositis, 246.e3
for osteoarthritis, 722 and hepatic lipidosis, 444 for sebaceous adenitis, 902
for osteochondrosis, 724 as malnutrition, 616.e3 Omeprazole
for osteosarcoma, 727 and panting, 751 for acid or alkali (corrosives) toxicosis, 14
for pain management, 931 Obsessive-compulsive disorder (OCD), 701–703 administration and dosage of, 1498
for panosteitis, 750 licking and barbering behavior as, 589.e2 for aspirin toxicosis, 83.e3
for patellar luxation, 764 Obstipation, 202–204, 1407a for esophagitis, 313
for periapical abscess, 8 Obstructive shock, 911 for gastric ulcer, 382
platelet dysfunction and, 790.e5 Obtunded, 197 for gastrinoma, 382.e3
for rheumatoid arthritis, 889 Occipital bone hypoplasia. See Chiari-like malformation for hydrocephalus, 483
for smoke inhalation, 920 Occlusive dressings, 910 for mast cell tumor, 634, 636
toxicosis from, 83.e3, 695–697 Occult urinary tract infection, 110.e2 for megaesophagus, 643
for uveitis, 1024 OCD. See Obsessive-compulsive disorder; Omphalocele, 1003
Nonulcerative keratitis, 465 Osteochondritis dissecans Oncogenes, 621
Nonunion, 357 Oclacitinib, 93, 1498 Oncotic pressure. See Colloid osmotic pressure (COP)
Nonvital (dead) teeth, 1089 for acute moist dermatitis, 26 Oncovin. See Vincristine
Norepinephrine drug interactions, 1510.e1t–1510.e5t Ondansetron
administration and dosage of, 1496 for eosinophilic granuloma complex, 301 administration and dosage of, 1498
for hypotension, 523.e4 Octreotide adverse effects of, 1510.e6t
for sepsis and septic shock, 908 administration and dosage of, 1498 antiemetic uses of, 25
Norflex, 108 for chylothorax, 173 for chemotherapy reactions, 155
Norfolk terrier, ichthyosis in, 214 for food-related hyperadrenocorticism, 489 for pancreatitis, 741
Normal daily water consumption, 812 for pancreatic adenocarcinoma, 739 sensitivity to, MDR1 mutation and, 639
Norman-Landing disease, 945.e2–945.e3 for superficial necrolytic dermatitis, 953 One-stage prothrombin time (OSPT). See Prothrombin
Normosol-M, 1510.e8t Ocufen. See Flurbiprofen time (PT)
Normosol-R, 1510.e8t Ocuflox. See Ofloxacin Onions
Nortriptyline Ocular bacterial isolates, 1202.e1 description of, 1351
for inappropriate elimination, 534 Ocular discharge, 703–704 toxicosis caused by, 707–708
toxicosis from, 72 Ocular disorders. See also Eye; Intraocular disease; specific Onslor. See Robenacoxib
Norvasc. See Amlodipine disorders Onychodystrophy, 176
Norwegian elkhound adhesive or glue exposure and, 33 Onychogryposis, 580
cutaneous neoplasia in, 230 red eye. See Red eye Onychomadesis, 176, 177.e1f
familial nephropathy in, 169 Ocular enlargement. See Buphthalmos Onychomycosis, 176–178
Fanconi syndrome in, 322 Ocular hypertension. See Glaucoma Onychorrhexis, 176
osteogenesis imperfecta in, 724.e2 Ocular injury, corneal/scleral trauma as cause of, o,p’DDD. See Mitotane (o,p’DDD)
renal tubular acidosis in, 879.e2 213–214 Open-mouth jaw locking, 708–710, 710f
stunted growth in, 946 Ocular larval migrans, Baylisascaris infection and, Open wounds, 120.e3
Norwegian forest cat, hypertrophic cardiomyopathy in, 114.e2–114.e3 Ophthalmic examination, 1139f
505 Ocular lymphoma, 522 Ophthalmoplegia, 846–847
Norwegian Lundehund Ocular melanosis, 563 Ophthalmoscope, 1138
lymphangiectasia in, 600 Ocular neoplasia, 559–561, 560f Opiates. See Opioids
protein-losing enteropathy in, 2.e3 Ocular pilocarpine test, 276.e2 Opioids
Norwich terrier Ocular position and movement, in neurologic classification of, 711
infertility in bitches, 539 examination, 1137 fetal adverse effects and, 818
paroxysmal dyskinesia in, 661 Ocular proptosis, orbital disease and, 716 for necrotizing fasciitis, 685
Nose. See also specific Nasal entries Ocular sarcoma, 214 for osteoarthritis, 722
cutaneous disorders of, 676–678, 677f Ocular size abnormalities, 705–706 for pain management, 931
folliculitis and furunculosis of, 15, 852 Oculomotor nerve deficits, 1210 for smoke inhalation, 920
foreign body of, 355 Odontoclastic resorptive lesion, 982 toxicosis from, 710–711
hyperkeratosis of, 215–216 Odontogenic fibroma, peripheral, 307–308, 307f, Opisthotonos, in herpesviral-infected puppies, 466
Nosebleed. See Epistaxis 712 Opportunistic fungal infections, 372–373, 373.e1f
Notoedric mange, and pinnal disease, 789 Odontogenic tumor, amyloid-producing, 712 Opsoclonus-myoclonus syndrome, 661–663
Nova Scotia duck tolling retriever Odontoma, 712 Optic nerve deficits, 1210
juvenile polyarteritis in, 568.e2 Odynophagia, 312 Optic nerve hypoplasia, 846–847
neck pain in, 683 Ofloxacin, 1498 Optic neuritis, 711.e2–711.e3
Novantrone. See Mitoxantrone Old-dog encephalitis, 271 Oral abscess, 6–7
Novolin-R, 1510.e5 Old English sheepdog Oral burns, electrocution and, 292
NPH insulin, for diabetes mellitus, 253 cerebellar cortical degeneration in, 149.e3 Oral cavity
NSAIDs. See Nonsteroidal antiinflammatory drugs dilated cardiomyopathy in, 263 adhesives or glues in, 33
(NSAIDs) gastric dilation/volvulus in, 377 epulides of, 306–309, 307f–308f, 712
Nuchal ligament, 684.e2 hormone-responsive incontinence in, 1011 foreign bodies in, 354.e2–354.e3
Nuclear medicine. See Scintigraphy immune-mediated hemolytic anemia in, 60 neoplasia of. See Oral tumors
Nuclear sclerosis, cataracts vs., 147–148 immune-mediated thrombocytopenia in, 972 Oral digestive enzyme replacement, 317
Nucleated red blood cells, white blood cell count affected MDR1 mutation in, 638–639 Oral dysphagia, 277
by, 1359 primary ciliary dyskinesia in, 174.e2 Oral erosions, feline calicivirus and, 141–143
Numorphan. See Oxymorphone urolithiasis in, 1014.e2 Oral examination, 1125–1127, 1126f, 1140–1142,
Nuprin. See Ibuprofen Oleander toxicosis, 143, 706–707, 707.e1f 1141f, 1142.e1f
Nursing difficulty, cleft palate and, 180 Oleandrin, 706 Oral lesions, and ptyalism, 833
Nutrition. See Diet; Dietary management Olecranon bursitis. See Elbow hygroma Oral malodor. See Halitosis
Nutritional osteodystrophy, 697 Oleptro. See Trazodone Oral papilloma, 752–754, 753f
Nutritional secondary hyperparathyroidism, 697–698 Olfactory nerve deficits, 1210 Oral supplementation. See Dietary supplementation
Nutritional support. See also Parenteral nutrition Oligoastrocytoma, spinal cord, 932 Oral tumors
coax feeding tips, 1199 Oligodendroglioma, spinal cord, 932 benign, 711–713, 713f
decision-making algorithm for, 1437.e4a Oligodontia, canine distemper and, 271 malignant, 714–716, 715f
in dysphagia, 278 Oligozoospermia, 541–543 melanoma, 644–645, 644f, 644.e1f, 1437a
in malnutrition, 616.e4 Oliguria, 23 rhabdomyosarcoma, 888.e2–888.e3
Nutritive metals, 37t Oliguric renal failure. See Acute kidney injury (AKI) squamous cell carcinoma, 939–942
Nyctalopia, 884 Ollulanus tricuspis, 380.e2–380.e3 Oral ulcers, 1002–1003, 1255
www.ExpertConsult.com